PMDA — authorised 26 September 2022
- Marketing authorisation holder: BRISTOL-MYERS SQUIBB K.K.
- Status: approved
🇯🇵 Sotyktu in Japan
PMDA authorised Sotyktu on 26 September 2022
Marketing authorisation
Sotyktu in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Sotyktu approved in Japan?
Yes. PMDA authorised it on 26 September 2022.
Who is the marketing authorisation holder for Sotyktu in Japan?
BRISTOL-MYERS SQUIBB K.K. holds the Japanese marketing authorisation.